1. Home
  2. RGEN vs KEP Comparison

RGEN vs KEP Comparison

Compare RGEN & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • KEP
  • Stock Information
  • Founded
  • RGEN 1981
  • KEP 1961
  • Country
  • RGEN United States
  • KEP South Korea
  • Employees
  • RGEN N/A
  • KEP N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • KEP Electric Utilities: Central
  • Sector
  • RGEN Health Care
  • KEP Utilities
  • Exchange
  • RGEN Nasdaq
  • KEP Nasdaq
  • Market Cap
  • RGEN 8.2B
  • KEP 9.4B
  • IPO Year
  • RGEN N/A
  • KEP N/A
  • Fundamental
  • Price
  • RGEN $142.03
  • KEP $8.40
  • Analyst Decision
  • RGEN Buy
  • KEP
  • Analyst Count
  • RGEN 10
  • KEP 0
  • Target Price
  • RGEN $188.38
  • KEP N/A
  • AVG Volume (30 Days)
  • RGEN 778.8K
  • KEP 105.0K
  • Earning Date
  • RGEN 10-29-2024
  • KEP 10-01-2024
  • Dividend Yield
  • RGEN N/A
  • KEP N/A
  • EPS Growth
  • RGEN N/A
  • KEP N/A
  • EPS
  • RGEN N/A
  • KEP 3.00
  • Revenue
  • RGEN $602,354,000.00
  • KEP $65,870,350,762.00
  • Revenue This Year
  • RGEN $0.08
  • KEP $5.48
  • Revenue Next Year
  • RGEN $12.97
  • KEP $3.16
  • P/E Ratio
  • RGEN N/A
  • KEP $5.59
  • Revenue Growth
  • RGEN N/A
  • KEP 12.78
  • 52 Week Low
  • RGEN $110.45
  • KEP $5.93
  • 52 Week High
  • RGEN $211.13
  • KEP $9.55
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 45.65
  • KEP 62.85
  • Support Level
  • RGEN $135.88
  • KEP $7.99
  • Resistance Level
  • RGEN $150.72
  • KEP $8.46
  • Average True Range (ATR)
  • RGEN 5.47
  • KEP 0.09
  • MACD
  • RGEN -0.88
  • KEP -0.01
  • Stochastic Oscillator
  • RGEN 36.09
  • KEP 82.65

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About KEP Korea Electric Power Corporation

Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment.

Share on Social Networks: